Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1612, 2007-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Erlotinib dominates docetaxel for NSCLC
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Access to resources
Recommend
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
Erlotinib dominates docetaxel for NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :
Erlotinib improves QOL in NSCLC
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
Erlotinib seals the deal in NSCLC treatment
Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. :